Donna Roy Grogan - Jul 29, 2022 Form 3 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role: Director
Signature: /s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol: CCCC
Transactions as of: Jul 29, 2022
Transactions value $: $0
Form type: 3
Date filed: 8/2/2022, 04:20 PM
Next filing: Oct 4, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney